Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging

Similar documents
Imaging in Ischemic Heart Disease: Role of Cardiac MRI

The role of Magnetic Resonance Imaging in the diagnosis of viability & Coronary Artery Disease

Sung A Chang Department of Internal Medicine, Division of Cardiology, Sungkyunkwan University School of Medicine, Samsung Medical Center

The Value of Stress MRI in Evaluation of Myocardial Ischemia

Cardiac Stress MRI: Detection of Ischemia. Disclosures: Dobutamine Stress MR. April 28, 2018

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Stress MRI is here to stay. Professor James Moon Barts Heart Centre UCL Director of Imaging

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

Role of CMR in heart failure and cardiomyopathy

Cardiac magnetic resonance imaging in rheumatoid arthritis: promising or misleading? Sophie Mavrogeni MD FESC

Advanced MR Imaging in Myocarditis

Newly Diagnosed Heart Failure patient: When to Order an MRI and Why

Acute chest pain: game changer or waste of resources? CMR one stop shop for function, structure and perfusion

Imaging and heart failure

Perfusion, Viability, Edema and Hemorrhage: How it Can (and Should) Change Clinical Practice. Rohan Dharmakumar, Ph.D.

A Light in the Dark: Cardiac MRI and Risk Mitigation. J. Ronald Mikolich MD Professor of Internal Medicine Northeast Ohio Medical University (NEOMED)

Cardial MRI; Approaching the Level of Gold Standard for Viability Assessment

Cardiology for the Practitioner Advanced Cardiac Imaging: Worth the pretty pictures?

The use of Cardiac CT and MRI in Clinical Practice

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

CMR stress Perfusion: what's new?

Current Indications for Cardiac MRI: What You See is What You Get?

Evaluation of Myocardial Viability: What Have We Learned from STICH? Professor of Medicine David Geffen School of Medicine at UCLA. Heart Failure (HF)

Case based interactive discussion Encourage debate Cover common conditions seen in MRI Give you the good and the bad of what we do ESC Guidelines and

MR Assessment of Myocardial Viability

Detection and Assessment of MI: Use of Imaging Methods. Robert O. Bonow, M.D.

Assessment of Ischemia and Viability

What the Cardiologist needs to know from Medical Images

ESC CONGRESS 2010 Stockholm, august 28 september 1, 2010

Usefulness of Delayed Enhancement by Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy as a Marker of Disease and Its Severity

Case based learning: CMR in Heart Failure

Current and Future Imaging Trends in Risk Stratification for CAD

Hybrid cardiac imaging Advantages, limitations, clinical scenarios and perspectives for the future

J. Schwitter, MD, FESC Section of Cardiology

Subha V. Raman, MD, MSEE, FACC, FAHA

Advanced Imaging MRI and CTA

8 th EuroCMR Meeting - Florence 2010 Start: Thursday, End: Saturday (+ CMR exam)

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Outils d évaluation myocardique par relaxométrie (Myomaps)

Coronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?

Cardiac CT and MRI. Ashraf Hamdan, MD. Sheba Medical Center. Sheba Medical Center Tel Hashomer. Leviev Heart Center

CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

27-year-old professionnal rugby player: asymptomatic

Rational use of imaging for viability evaluation

João A. C. Lima, MD Professor of Medicine and Radiology Johns Hopkins Hospital

Coronary Revascularization for Severe LV Dysfunction Is s. Is the concept of viability testing still viable?

Cardiovascular magnetic resonance in acute myocardial infarction

Case based learning: CMR in Heart Failure

Gated blood pool ventriculography: Is there still a role in myocardial viability?

Benefit of Performing PCI Based on FFR

63 yo woman with chest pain

Assessment Of Myocardial Viability

The Role of Nuclear Imaging in Heart Failure

Multimodality Cardiac Imaging: Its Use in the Era of Value-based Reimbursement

Update in Nuclear Imaging of Amyloidosis and Sarcoidosis

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

MD F A F C A C MAS A N S C

Myocardial Fibrosis in Heart Failure

CT or PET/CT for coronary artery disease

Evaluating Clinical Risk and Guiding management with SPECT Imaging

Direct Ischaemia imaging and other Competing technologies

Current clinical applications of cardiovascular magnetic resonance imaging

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Klinische Anwendung und neue Entwicklungen: Welches Verfahren für welche Indika:on? Kardiales MR. 17. Zürcher Herzkurs

Coronary interventions

Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging and Major Adverse Coronary Events

Current Guidelines for Diagnosis of AMI Chest pain ST change on EKG Cardiac Enzymes

Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology

Non-Invasive Evaluation of Coronary Vasospasm Using a Combined Hyperventilation and Cold-Pressure-Test Perfusion CMR Protocol

Cardiac Risk Factors and Noninvasive Cardiac Diagnosis-ECG, ECHO, et al. Martin C. Burke, DO, FACOI ACOI IM Board Review Course 2018

Newer Methods for Noninvasive Assessment of Myocardial Perfusion

Advanced Cardiac Imaging in Heart Failure Echo and MRI Beyond the LVEF

Coronary artery disease (CAD): Fractional Flow Reserve (FFR) for Pilots Risk Assessment. B. Haaff, R. Quast

Cardiac MRI: Appropriateness. Scott Mattson, DO, FACC Lutheran Medical Group Fort Wayne, IN

: A SELECTION OF ARTICLES CARDIAC MR AND CT. JN Dacher, Rouen

Myocardial viability testing. What we knew and what is new

New Insight about FFR and IVUS MLA

Why Cardiac MRI? Presented by:

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Myocardial Stress Perfusion Imaging using CMR

Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy

ASSESSMENT OF CARDIAC AMYLOIDOSIS BY USING 18F-SODIUM FLUORIDE PET/MR IMAGING.

PET myocard perfusion & viability Riemer Slart

DECLARATION OF CONFLICT OF INTEREST. Grant support: Philips Healthcare Bayer Schering

Cardiac MRI: Cardiomyopathy

Women and Coronary Artery Disease:

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

while the absence of LGE-CMR may reduce the need for ICD implantation in patients with NIDM who are at low risk for future VF/VT or SCD.

What s New in Cardiac MRI

I have no financial disclosures

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

Pathophysiology of ischemia-reperfusion injury (and how to protect against it )

CARDIAC MULTIMODALITY IMAGING: Informing better decisions - or just costly pictures?

Insights into Viability- Function and Contractile Reserve

MPS and Calcium Score in asymptomatic patient F. Mut, J. Vitola

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

Metabolic Imaging. Magnetic resonance imaging perfusion to assess transmural flow distribution METABOLIC IMAGING - AMEDEO CHIRIBIRI

Transcription:

Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging Oliver Bruder Department of Cardiology Elisabeth Hospital Essen Germany

Growth of CV Imaging Shaw; JACCi 2010

Novel Paradigm for CV Imaging Research Diagnostic Accuracy Clinical Utility Patient Outcomes Societal Outcomes Technical quality Reliability Reproducibility Sensitivity/ specificity Impact on MD decision making: i)diagnostic ii)therapeutic Impact on patient management Increase survival +quality of life Comparative Effectiveness of imaging-driven clinical pathways Cost effectiveness

Does the patient live longer or better due to the imaging procedure...? Shaw SCMR Phoemix 2010

Benefits / Risks of CV Imaging - Avoid Invasiveness

Benefits / Risks of CV Imaging - Avoid Radiation

CMR in Clinical Routine Evidence from routine CMR in 11,040 patients. EuroCMR registry an initiative of the ESC WG CMR Bruder; JACC 2009

Late Gadolinium Enhancement SPECT CMR Histology Wagner; Lancet 2003

LGE detects subendocardial infarction 50% 57% 77 % 100% Wagner; Lancet 2003

How does it work? Normal Acute Damage Scar Na Na Na Na Na K K Na Na Na Na Na K Na K K K K Na Na Na Na Na Na Na K K K Na Na Na Intact Cell Membran Ruptured Cell Membran Collagen Matrix Mahrholdt; EHJ 2005

Ischemic Wavefront: Subendocardial LGE in CAD! < 2 Hours 2-6 Hours > 6 Hours Reimer; Circulation 1977, Mahrholdt; EHJ 2005

CMR Infarct Transmurality Predicts Recovery of Function Kim; NEJM 2000

Viability, Intervention, and Prognosis Allman; JACC 2002

Suspected CAD Impact of Unrecognized SCAR LGE present n=44 195 patients with suspected CAD referred for CA, no hx of myocardial infarction, no infarct scar on ECG Kwong; Circ 2006

Perspective T2 Imaging Friedrich; JACC 2008

T2 CMR Myocardial Salvage in Retrospection Salvageable myocardium = T2 area - LGE infarct size (1 week following infarction) Carlsson; JACC Imaging 2009

CAD or DCM: Two Patients with New Onset Heart Failure Patient A (45 yr., male) Patient B (57 yr., male) Courtesy H. Mahrholdt Stuttgart

Two similar Patients Patient A Patient B Courtesy H. Mahrholdt Stuttgart

Two similar Patients Patient A Patient B Contrast CMR Courtesy H. Mahrholdt Stuttgart

Mid-wall LGE in DCM McCrohon; Circulation 2003

Mid-wall LGE in DCM Prognostic Significance Assomull; JACC 2006

Contrast CMR in HCM A B Roberts & Roberts Patient 2 Basso et al. Patient 5 Mahrholdt; EHJ 2005

LGE in HCM Prognostic Significance Bruder; JACC 2010

Contrast CMR in Amyloidosis NECROPSY HISTOLOGY CMR LAX CMR SAX Mahrholdt; EHJ 2005

Contrast CMR in Sarcoidosis NECROPSY CMR LAX CMR SAX Mahrholdt; EHJ 2005

Contrast CMR in Myocarditis EXVIVO Shirani et al. A B CMR Mahrholdt et al. Mahrholdt; EHJ 2005

Clinical Implication CMR Guides EMB Mahrholdt; Eur Heart J 2005, Mahrholdt; Circulation 2006

Contrast CMR Algorithm Mahrholdt; Eur Heart J 2005

CMR Stress Perfusion Stress perfusion RV contrast LV contrast Myocardium

65 female suspected CAD

Perfusion-Enhancement Algorithm for Suspected CAD LGE (1) infarct scar, CAD (2) exclusion (3) ischemia, CAD (4) exclusion, artefact (dark rim) CAD STRESS + REST - CAD Klem; JACC 2006, Mahrholdt; Heart 2007

CMR or SPECT - Suspected CAD MR-IMPACT: double blinded, randomized, multicenter, multivendor trial, 241 p undergoing cath. CMR perfusion superior to SPECT for multivessel disease. Schwitter; Eur Heart Journal 2008

SPECT: Prognostic Evidence from Large Patient Cohorts n = 5381 Hachamovitch; Circulation 1998

Stress CMR - Prognosis n = 513 MRP - Adenosine stress perfusion DSMR - Dobutamine stress CMR < 1% annual mortality rate with a normal stress CMR Jahnke; Circulation 2007

Impact of routine CMR on Patient Management Bruder; JACC 2009

Impact - Age Bruder; JACC 2009

Procedures NOT Performed Following CMR Bruder; JACC 2009

Summary CMR provides combined information on morphology, function, perfusion and non invasive tissue characterization CMR is superior to competing imaging modalities with many clinical indications CMR has a strong prognostic impact CMR guided therapy warrants further scientific evaluation

What we need! Megatrials with clinical questions meaningful to large parts of the population (suspected CAD, heart failure) Registries (EuroCMR registry) Comparative clinical effectiveness studies Comparing imaging-guided clinical pathways (ISCHEMIA trial)

EuroCMR Registry Goals Bruder; JACC 2009

www.eurocmr-registry.com

Imaging Saves Lives: An Evidence-Based Choice of Modality Magnetic Resonance Imaging